UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29089 Agenus Inc. (exact name of registrant as specified in its charter) Delaware 06-1562417 (State or other jurisdiction of (I.R.S. Employer i ...

Agenus Inc. (NASDAQ:AGEN) Q3 2021 Earnings Conference Call November 9, 2021 8:30 AM ET Company Participants Divya Vasudevan - Investor Relations Garo Armen - Chairman and Chief Executive Officer Jennifer Buell - Chief Executive Officer, MiNK Therapeutics Steven O’Day - Chief Medical Officer Christine Klaskin - Vice President, Finance Conference Call Participants Mayank Mamtani - B. Riley Securities Jason Bouvier - Jefferies Matt Phipps - William Blair Operator Good day and thank you for standing by. Welcome ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29089 Agenus Inc. (exact name of registrant as specified in its charter) Delaware 06-1562417 (State or other jurisdiction of incorpora ...

Agenus Inc. (NASDAQ:AGEN) Q2 2021 Earnings Conference Call August 9, 2021 8:30 AM ET Company Participants Jan Medina – Director-Investor Relations Garo Armen – Chairman and Chief Executive Officer Jennifer Buell – President and Chief Operating Officer Andy Hurley – Chief Commercial Officer Christine Klaskin – Vice President-Finance Steven O'Day – Chief Medical Officer Conference Call Participants Kelly Shi – Jefferies Mayank Mamtani – B. Riley Securities Matt Phipps – William Blair Operator Good morning, la ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29089 Agenus Inc. (exact name of registrant as specified in its charter) Delaware 06-1562417 (State or other jurisdiction of incorporation ...

Agenus Inc. (NASDAQ:AGEN) Q1 2021 Earnings Conference Call May 6, 2021 8:30 AM ET Company Participants John Medina – Director-Investor Relations Garo Armen – Chairman and Chief Executive Officer Jennifer Buell – President and Chief Operating Officer Steven O'Day – Chief Medical Officer Christine Klaskin – Vice President of Finance Conference Call Participants Mayank Mamtani – B. Riley Securities Jason Bouvier – Jefferies Operator Good morning, ladies and gentlemen. Thank you for standing by, and welcome to ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29089 Agenus Inc. (exact name of registrant as specified in its charter) Delaware 06-1562417 (State or other jurisdiction of incorporation ...

Agenus Inc. (NASDAQ:AGEN) Q4 2020 Earnings Conference Call March 15, 2020 8:30 AM ET Company Participants Jan Medina - Director of Investor Relations Garo Armen - Chairman & Chief Executive Officer Jennifer Buell - President & Chief Operating Officer Andy Hurley - Chief Commercial Officer Christine Klaskin - Vice President of Finance Steven O'Day - Chief Medical Officer Conference Call Participants Mayank Mamtani - B. Riley Securities Matt Phipps - William Blair Operator Good morning, ladies and gentlemen. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | --- | --- | |------------------------------------------------------------------|----------------------------------------------------------------------------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-29089 Agenus Inc. (exact name of registrant as specified in its charter) Delaware 06-1562417 (State or other jurisdiction of incorpora ...